
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.2K | -- | -- | -- | -- | |
Revenue Growth (YoY) | 33.37% | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $2.5M | $4.6M | $16.1M | $7.9M | $10.6M | |
Selling, General & Admin | $1.9M | $3.7M | $7.3M | $6.4M | $6.2M | |
Other Inc / (Exp) | -- | -$1.1M | $5.6M | $1.3M | $19.7M | |
Operating Expenses | $4.4M | $8.3M | $23.4M | $14.3M | $16.8M | |
Operating Income | -$4.4M | -$8.3M | -$23.4M | -$14.3M | -$16.8M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.4M | -$9.8M | -$18.1M | -$13.2M | $2.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$4.4M | -$9.8M | -$18.1M | -$13.2M | $2.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.4M | -$9.8M | -$18.1M | -$13.2M | $2.8M | |
Basic EPS (Cont. Ops) | -$0.94 | -$1.69 | -$2.41 | -$1.07 | $0.11 | |
Diluted EPS (Cont. Ops) | -$0.94 | -$1.69 | -$2.41 | -$1.07 | $0.11 | |
Weighted Average Basic Share | $4.8M | $5.8M | $7.5M | $12.3M | $25.9M | |
Weighted Average Diluted Share | $4.8M | $5.8M | $7.5M | $12.3M | $26.5M | |
EBITDA | -$4.4M | -$9.3M | -$17.8M | -$13M | $2.9M | |
EBIT | -$4.4M | -$9.4M | -$17.8M | -$13M | $2.9M | |
Revenue (Reported) | $1.2K | -- | -- | -- | -- | |
Operating Income (Reported) | -$4.4M | -$8.3M | -$23.4M | -$14.3M | -$16.8M | |
Operating Income (Adjusted) | -$4.4M | -$9.4M | -$17.8M | -$13M | $2.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $153.6K | $1.9M | $3.5M | $2.1M | $5.5M | |
Selling, General & Admin | $307.7K | $2M | $1.5M | $1.6M | $2M | |
Other Inc / (Exp) | -$5.6M | $2M | $11.2K | $118.3K | $112.2K | |
Operating Expenses | $461.3K | $3.9M | $5M | $3.7M | $7.5M | |
Operating Income | -$461.3K | -$3.9M | -$5M | -$3.7M | -$7.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Basic EPS (Cont. Ops) | -$1.43 | -$0.29 | -$0.58 | -$0.19 | -$0.21 | |
Diluted EPS (Cont. Ops) | -$1.43 | -$0.29 | -$0.58 | -$0.19 | -$0.21 | |
Weighted Average Basic Share | $4.9M | $7.2M | $8.6M | $19.5M | $34.9M | |
Weighted Average Diluted Share | $4.9M | $7.2M | $8.6M | $19.5M | $34.9M | |
EBITDA | -$6M | -$1.9M | -$5M | -$3.6M | -$7.3M | |
EBIT | -$6M | -$1.9M | -$5M | -$3.6M | -$7.3M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$461.3K | -$3.9M | -$5M | -$3.7M | -$7.5M | |
Operating Income (Adjusted) | -$6M | -$1.9M | -$5M | -$3.6M | -$7.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $1.9M | $6.3M | $17.7M | $6.5M | $14M | |
Selling, General & Admin | $1.7M | $5.4M | $6.7M | $6.5M | $6.6M | |
Other Inc / (Exp) | -$5.6M | $6.4M | $3.6M | $1.4M | $19.7M | |
Operating Expenses | $3.6M | $11.7M | $24.4M | $13M | $20.6M | |
Operating Income | -$3.6M | -$11.7M | -$24.4M | -$13M | -$20.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$9.1M | -$5.8M | -$20.9M | -$11.9M | -$933.9K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$9.2M | -$5.9M | -$20.9M | -$11.9M | -$933.9K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9.1M | -$5.8M | -$20.9M | -$11.9M | -$933.9K | |
Basic EPS (Cont. Ops) | -$2.36 | -$0.78 | -$2.70 | -$0.84 | -$0.05 | |
Diluted EPS (Cont. Ops) | -$2.36 | -$0.78 | -$2.70 | -$0.84 | -$0.05 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$9.1M | -$5.2M | -$20.8M | -$11.6M | -$933.9K | |
EBIT | -$9.1M | -$5.2M | -$20.8M | -$11.6M | -$933.9K | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$3.6M | -$11.7M | -$24.4M | -$13M | -$20.6M | |
Operating Income (Adjusted) | -$9.1M | -$5.2M | -$20.8M | -$11.6M | -$933.9K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $153.6K | $1.9M | $3.5M | $2.1M | $5.5M | |
Selling, General & Admin | $307.7K | $2M | $1.5M | $1.6M | $2M | |
Other Inc / (Exp) | -$5.6M | $2M | $11.2K | $118.3K | $112.2K | |
Operating Expenses | $461.3K | $3.9M | $5M | $3.7M | $7.5M | |
Operating Income | -$461.3K | -$3.9M | -$5M | -$3.7M | -$7.5M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Basic EPS (Cont. Ops) | -$1.43 | -$0.29 | -$0.58 | -$0.19 | -$0.21 | |
Diluted EPS (Cont. Ops) | -$1.43 | -$0.29 | -$0.58 | -$0.19 | -$0.21 | |
Weighted Average Basic Share | $4.9M | $7.2M | $8.6M | $19.5M | $34.9M | |
Weighted Average Diluted Share | $4.9M | $7.2M | $8.6M | $19.5M | $34.9M | |
EBITDA | -$6M | -$1.9M | -$5M | -$3.6M | -$7.3M | |
EBIT | -$6M | -$1.9M | -$5M | -$3.6M | -$7.3M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$461.3K | -$3.9M | -$5M | -$3.7M | -$7.5M | |
Operating Income (Adjusted) | -$6M | -$1.9M | -$5M | -$3.6M | -$7.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $806.9K | $16.9M | $5.9M | $12.6M | $13.3M | |
Short Term Investments | $33K | $33.3K | $31K | $32.4K | $33.1K | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $102K | $684.2K | $920.4K | $681.2K | $5.5M | |
Other Current Assets | -- | $4.4K | $4.6K | $33.2K | $47.3K | |
Total Current Assets | $972.9K | $17.7M | $6.9M | $13.6M | $18.9M | |
Property Plant And Equipment | $78.1K | $4.7K | $320 | -- | -- | |
Long-Term Investments | $2.4K | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $1.1M | $17.7M | $6.9M | $13.6M | $18.9M | |
Accounts Payable | $437.5K | $409K | $3M | $7.8M | $1.7M | |
Accrued Expenses | $46.2K | $520.1K | $3.4M | $987.8K | $442.6K | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.9M | $929.1K | $6.4M | $9.3M | $2.2M | |
Long-Term Debt | -- | $3.9M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.9M | $12.1M | $8.3M | $9.9M | $2.4M | |
Common Stock | $41.4M | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -$187.9K | -$195.4K | -$371.2K | -$371.2K | |
Common Equity | -$796.7K | $5.7M | -$1.3M | $3.8M | $16.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$796.7K | $5.7M | -$1.3M | $3.8M | $16.5M | |
Total Liabilities and Equity | $1.1M | $17.7M | $6.9M | $13.6M | $18.9M | |
Cash and Short Terms | $839.9K | $17M | $5.9M | $12.6M | $13.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $7M | $13.8M | $3.3M | $2.5M | $8.4M | |
Short Term Investments | $33.3K | $33.7K | $31.1K | $32.4K | $33.1K | |
Accounts Receivable, Net | $189.4K | $100.8K | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $156.5K | $521.9K | $533.9K | $918.6K | $5.2M | |
Other Current Assets | -- | -- | $5.8K | $23.5K | $22.5K | |
Total Current Assets | $7.3M | $14.4M | $4.4M | $3.5M | $13.6M | |
Property Plant And Equipment | $68.2K | $5K | -- | -- | -- | |
Long-Term Investments | $310 | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $7.4M | $14.4M | $4.4M | $3.5M | $13.6M | |
Accounts Payable | $241.8K | $644.8K | $7M | $1.4M | $1.2M | |
Accrued Expenses | $112.9K | $745.5K | $1.7M | $839K | $2.4M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.8M | $1.4M | $8.7M | $2.6M | $4.1M | |
Long-Term Debt | $3.6M | $4.1M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $14.3M | $10.7M | $10.6M | $3.5M | $4.2M | |
Common Stock | $42.4M | $57.7M | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -$199.7K | -$371.2K | -$371.2K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$6.9M | $3.7M | -$6.2M | $77.1K | $9.5M | |
Total Liabilities and Equity | $7.4M | $14.4M | $4.4M | $3.5M | $13.6M | |
Cash and Short Terms | $7M | $13.8M | $3.4M | $2.5M | $8.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.4M | -$9.8M | -$18.1M | -$13.2M | $2.8M | |
Depreciation & Amoritzation | $12.3K | $45.8K | $11.2K | $21.2K | -- | |
Stock-Based Compensation | $205.4K | $515.6K | $487.6K | $271.5K | $825.8K | |
Change in Accounts Receivable | $27.2K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.4M | -$9.3M | -$17M | -$10.8M | -$27.2M | |
Capital Expenditures | $85.2K | -- | -- | -- | -- | |
Cash Acquisitions | -$2.4K | -- | -- | -- | -- | |
Cash From Investing | -$87.7K | $94.6K | -$2K | -$1.4K | -$690 | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $6.9M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $3M | $25.5M | $6.5M | $17.7M | $27.9M | |
Beginning Cash (CF) | $1.3M | $806.9K | $16.9M | $5.9M | $12.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$496.2K | $16.3M | -$10.5M | $6.9M | $693K | |
Ending Cash (CF) | $806.9K | $16.9M | $5.9M | $12.6M | $13.3M | |
Levered Free Cash Flow | -$3.5M | -$9.3M | -$17M | -$10.8M | -$27.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Depreciation & Amoritzation | $12.1K | $3.1K | $1.6K | -- | -- | |
Stock-Based Compensation | -$54.1K | $124.9K | $132.5K | $63.6K | $245.3K | |
Change in Accounts Receivable | -$158K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$777.5K | -$3.4M | -$2.6M | -$10.3M | -$4.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$2.1K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $6.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $6.9M | -- | -- | $190.3K | -- | |
Beginning Cash (CF) | $815.2K | $16.9M | $5.9M | $12.6M | $13.3M | |
Foreign Exchange Rate Adjustment | -- | $179.1K | $17.7K | -- | -- | |
Additions / Reductions | $6.1M | -$3.4M | -$2.6M | -$10.1M | -$4.9M | |
Ending Cash (CF) | $7M | $13.8M | $3.3M | $2.5M | $8.4M | |
Levered Free Cash Flow | -$777.5K | -$3.4M | -$2.6M | -$10.3M | -$4.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9.2M | -$5.9M | -$20.9M | -$11.9M | -$933.9K | |
Depreciation & Amoritzation | $23.2K | $36.8K | $9.7K | $19.6K | -- | |
Stock-Based Compensation | $82.2K | $694.6K | $495.3K | $202.6K | $1M | |
Change in Accounts Receivable | -$134.2K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$3.2M | -$11.9M | -$16.2M | -$18.6M | -$21.8M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -$2.4K | -- | -- | -- | -- | |
Cash From Investing | -- | $92.6K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $9.3M | -- | -- | $17.9M | $27.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6M | $6.8M | -$9.7M | -$635.7K | $5.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$3.3M | -$11.9M | -$16.2M | -$18.6M | -$21.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$6M | -$2.1M | -$5M | -$3.6M | -$7.3M | |
Depreciation & Amoritzation | $12.1K | $3.1K | $1.6K | -- | -- | |
Stock-Based Compensation | -$54.1K | $124.9K | $132.5K | $63.6K | $245.3K | |
Change in Accounts Receivable | -$158K | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$777.5K | -$3.4M | -$2.6M | -$10.3M | -$4.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$2.1K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $6.9M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $6.9M | -- | -- | $190.3K | -- | |
Beginning Cash (CF) | $815.2K | $16.9M | $5.9M | $12.6M | $13.3M | |
Foreign Exchange Rate Adjustment | -- | $179.1K | $17.7K | -- | -- | |
Additions / Reductions | $6.1M | -$3.4M | -$2.6M | -$10.1M | -$4.9M | |
Ending Cash (CF) | $7M | $13.8M | $3.3M | $2.5M | $8.4M | |
Levered Free Cash Flow | -$777.5K | -$3.4M | -$2.6M | -$10.3M | -$4.9M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.